Related Experiment Video
Updated: Aug 14, 2026

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
Published on: February 5, 2015
Biotransformation of organophosphorus compounds relative to delayed neurotoxicity
Abstract:
In summary, although there is considerable information on he biotransformation of OP compounds, there are some deficiencies in our knowledge of the biotransformation of phosphonothionate delayed neurotoxicants. Various anomalies, such as the species variations, limited absorption and unique disposition, phenyl phosphonothionate vs. alkyl phosphonothionate potency, O-methyl phenylphosphonothionate vs. O-ethyl phenylphosphonothionate potency, and the relative contributions of various activation and detoxication pathways still exist. The understanding of the syndrome of delayed neurotoxicity will come from receptor/mechanism studies, but by increasing our knowledge of comparative biotransformation, we can insure that our concepts are less distorted by "extraneous" influences. Moreover, since the ultimate goal is to define the syndrome as it relates to the whole organism for predictive and safety considerations, influences such as biotransformation and disposition are no longer extraneous but critical.
Insights
Knowledge gaps persist in understanding the biotransformation of phosphonothionate delayed neurotoxicants, impacting safety assessments. Further research into comparative biotransformation is critical for a comprehensive understanding of neurotoxicity.
Area of Science:
- Toxicology
- Biochemistry
- Environmental Health
Background:
- Organophosphate (OP) compounds are widely studied for their biotransformation.
- Significant gaps exist in understanding the biotransformation of phosphonothionate delayed neurotoxicants.
Purpose of the Study:
- To highlight deficiencies in current knowledge regarding phosphonothionate neurotoxicant biotransformation.
- To emphasize the importance of comparative biotransformation studies for understanding delayed neurotoxicity.
Main Methods:
- Review of existing literature on OP and phosphonothionate biotransformation.
- Identification of anomalies and areas requiring further investigation.
Main Results:
- Anomalies include species variations, limited absorption, unique disposition, and variable potency related to chemical structure.
- Relative contributions of activation and detoxication pathways remain unclear.
Conclusions:
- Understanding delayed neurotoxicity requires addressing biotransformation and disposition.
- Comparative biotransformation studies are crucial to avoid distorted concepts and ensure accurate safety and predictive considerations for the whole organism.
Related Concept Videos
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Drug Toxicity: Dose-Dependent Reactions
Microbial Bioremediation of Pesticides

